Cargando…
Facilitated electrical cardioversion: does the selection of the antiarrhythmic drug matter?
Autores principales: | Dan, Gheorghe-Andrei, Dobrev, Dobromir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727018/ https://www.ncbi.nlm.nih.gov/pubmed/31508481 http://dx.doi.org/10.1016/j.ijcha.2019.100416 |
Ejemplares similares
-
Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2018) -
Emerging Antiarrhythmic Drugs for Atrial Fibrillation
por: Saljic, Arnela, et al.
Publicado: (2022) -
Recent Advances in Antiarrhythmic Drug Therapy
por: Saljic, Arnela, et al.
Publicado: (2023) -
Stretching the limits of antiarrhythmic drug therapy: The promise of small-conductance calcium-activated potassium channel blockers()
por: Heijman, Jordi, et al.
Publicado: (2021) -
Non-traditional antiarrhythmic drugs as upstream and downstream dam for atrial fibrillation burden
por: Dan, Gheorghe-Andrei
Publicado: (2020)